Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 6, 2005
J Am Soc Nephrol 16: 2598-2607, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004121049

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004121049v1
16/9/2598    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khundmiri, S. J.
Right arrow Articles by Lederer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khundmiri, S. J.
Right arrow Articles by Lederer, E.

Cell and Transport Physiology

Parathyroid Hormone Regulation of Na+,K+-ATPase Requires the PDZ 1 Domain of Sodium Hydrogen Exchanger Regulatory Factor-1 in Opossum Kidney Cells

Syed Jalal Khundmiri*, Edward J. Weinman{dagger},{ddagger}, Deborah Steplock{dagger}, Judith Cole§, Aamir Ahmad*, Patrick D. Baumann*, Michelle Barati*, Madhavi J. Rane* and Eleanor Lederer*,||

* Department of Medicine, University of Louisville, Louisville, Kentucky; {dagger} Department of Medicine, University of Maryland, Baltimore, Maryland; {ddagger} Veterans Administration Medical Center, Baltimore, Maryland; § Department of Biology, University of Memphis, Memphis, Tennessee; and || Veterans Administration Medical Center, Louisville, Kentucky

Address correspondence to: Dr. Syed Jalal Khundmiri, University of Louisville, Kidney Disease Program, 570 South Preston Street, Baxter I Building, Suite 102, Louisville, KY 40202. Phone: 502-852-0014; Fax: 502-852-4384; E-mail: syed.khundmiri{at}louisville.edu

Received for publication December 6, 2004. Accepted for publication June 6, 2005.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
It was demonstrated that expression of murine sodium hydrogen exchanger regulatory factor (NHERF-1) lacking the ezrin-binding domain blocks parathyroid hormone (PTH) regulation of Na+,K+-ATPase in opossum kidney (OK) cells. The hypothesis that the NHERF-1 PDZ domains contribute to PTH regulation of Na+,K+-ATPase was tested by comparison of PTH regulation of Na+,K+-ATPase in wild-type OK (OK-WT) cells, NHERF-deficient OKH cells, OK-WT transfected with siRNA for NHERF (NHERF siRNA OK-WT), and OKH cells that were stably transfected with full-length NHERF-1 or constructs with mutated PDZ domains. OKH cells and NHERF siRNA OK-WT showed decreased expression of NHERF-1 but equivalent expression of ezrin and Na+,K+-ATPase {alpha}1 subunit when compared with OK-WT cells. PTH decreased Na+,K+-ATPase activity and stimulated phosphorylation of the Na+,K+-ATPase {alpha}1 in OK-WT cells but not in NHERF-deficient cells. Rubidium (86Rb) uptake was equivalent in OK-WT, OKH, and OKH cells that were transfected with all but the double PDZ domain mutants. PTH decreased 86Rb uptake significantly in OK-WT but not in OKH cells. PTH also significantly inhibited 86Rb uptake in OKH cells that were transfected with full-length NHERF-1 or NHERF-1 with mutated PDZ 2 but not in OKH cells that were transfected with mutated PDZ 1. Transfection with NHERF expressing both mutated PDZ domains resulted in diminished basal 86Rb uptake that was not inhibited further by PTH. PTH stimulated protein kinase C{alpha} activity and {alpha}1 subunit phosphorylation in OK-WT but not in NHERF-deficient cells. Transfection of OKH cells with NHERF constructs that contained an intact PDZ1 domain restored PTH-stimulated protein kinase C{alpha} activity and {alpha}1 subunit phosphorylation. These results demonstrate that NHERF-1 is necessary for PTH-mediated inhibition of Na+,K+-ATPase activity and that the inhibition is mediated through the PDZ1, not PDZ2, domain.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
Na+,K+-ATPase is a highly abundant basolateral membrane (BLM) protein in proximal renal tubule that is responsible for the maintenance of intracellular sodium and potassium balance (1). The activity of this protein creates the driving force for the transport of sodium from the tubular lumen to the renal vasculature, a determining factor in regulation of total body sodium homeostasis, extracellular fluid volume status, and BP control. Abnormalities in the regulation of Na+,K+-ATPase activity have been implicated in the pathogenesis of some forms of salt-sensitive hypertension. Na+,K+-ATPase activity is regulated by a multitude of hormones and neuropeptides through activation of several signaling pathways (1). One of the major regulators of proximal renal tubule sodium pump activity is parathyroid hormone (PTH) (2,3).

Mahon et al. (4,5) demonstrated a critical role for sodium hydrogen exchanger regulatory factor (NHERF) in the regulation of PTH receptor signaling. NHERF are PDZ (PSD-95, Drosophila discs large, ZO-1) proteins that are centrally involved in regulation of proximal renal tubule cell transport processes (611). Two members of the NHERF family have been described to exhibit unique expression patterns and functions in kidney (1215). In mouse kidney, NHERF-1 is expressed predominantly in the microvilli of the proximal tubule in association with NHE-3, the type IIa sodium-phosphate co-transporter (NaPi IIa), and ezrin and is responsible for facilitation of cAMP-mediated regulation of NHE-3 and apical membrane targeting of NaPi IIa. NHERF-2 is expressed at the base of the microvilli associated with NHE-3 and ezrin but not NaPi IIa and facilitates calcium-mediated regulation of NHE-3.

The two distinct PDZ domains of NHERF exhibit divergent amino acid sequences and binding specificities that permit the construction and localization of extended heterogeneous protein interaction units (1618). For example, the N terminal PDZ domain (amino acids 77 to 82; PDZ1) binds to the {beta}2 adrenergic receptor (19), NaPi IIa (20), phospholipase C (PLC) {beta}1,2 (21), and RACK-1 (22), whereas the C terminal PDZ domain (amino acids 217 to 222; PDZ2) binds to NHE-3 (23) and ROMK (24). Some proteins, notably the cystic fibrosis conductance regulator, are capable of binding either PDZ domain (25,26).

We recently demonstrated that expression of a murine NHERF-1 construct lacking the C-terminal ezrin-binding domain (amino acids 325 to 355) completely abolishes regulation of Na+,K+-ATPase activity by PTH in opossum kidney (OK) cells, a model of mammalian renal proximal tubule (27). The role of the two PDZ domains of NHERF-1 in the regulation of Na+,K+-ATPase activity and expression remains unknown. Binding of NHE-3 to the PDZ2 domain of NHERF-1 is necessary for its regulation by PTH (23). In addition, Breton et al. and others (28,29) have shown that the B1 subunit of H+-ATPase, a member of the V-type ATPases, co-localizes through its PDZ-binding domain with NHERF. On the basis of these observations, we hypothesized that one or both PDZ domains of NHERF are also required for PTH regulation of Na+,K+-ATPase.

To address this hypothesis, we compared the ability of PTH to regulate {alpha}1 subunit phosphorylation and Na+,K+-ATPase activity in wild-type OK cells (OK-WT) and in two models of NHERF-deficient OK cells. OK-WT cells express only NHERF-1 and not NHERF-2, making them an excellent model to investigate the role of this specific NHERF isoform in regulation of transport in the proximal renal tubule cell (30). To examine the specific role of the two PDZ domains, we stably transfected a NHERF-deficient OK cell line, OKH cells (3133), with either full-length human NHERF-1 or NHERF-1 constructs expressing nonfunctional PDZ 1, PDZ 2, or both PDZ domains. We demonstrated that the ability of PTH to phosphorylate the {alpha}1 subunit and to regulate Na+,K+-ATPase activity was dependent on the expression of NHERF-1 with a normal PDZ 1 domain.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
PTH (134) was purchased from Bachem Biosciences Inc. (King of Prussia, PA). Polyclonal antibodies against Na+,K+-ATPase {alpha}1-subunit (for immunoprecipitation [IP]) and protein kinase C (PKC) activity kit were purchased from Upstate Biotechnology (Waltham, MA). MAb against Na+,K+-ATPase {alpha}1-subunit (for Western blots) were purchased from Sigma-RBI (Natick, MA). Antibodies against ezrin were purchased from Sigma (St. Louis, MO). Antibodies against PKC{alpha} were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phosphoserine antibodies were purchased from Zymed (San Francisco, CA). Geneporter transfection and Genesilencer siRNA transfection reagents were purchased from Gene Therapy Systems Inc. (San Diego, CA). All other chemicals were purchased from Sigma unless otherwise specified. Anti-NHERF antibodies were previously characterized by E.J.W. and his colleagues (14).

NHERF Mutations
The human NHERF-1 cDNA was inserted into pET-30-(a)+ (Novagen, Madison, WI) to generate a hexahistidine-fused NHERF-1 (His-NHERF-1), which then was transferred to pcDNA 3.1Hygro+ for expression in mammalian cells. Similarly, cDNA encoding NHERF-1 with alanine substitutions (GAGA) in the core peptide-binding sequence, GYGF (amino acids 77 to 82 and 217 to 222), that inactivates the individual PDZ domains were inserted into pcDNA 3.1Hygro+. All cDNA were confirmed by double-stranded DNA sequencing (23).


    Cell Culture
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
The OK cells are a continuous cell line derived from Virginia opossum and a widely used model for mammalian renal proximal tubule (34). OKH cells are a clonal subline of the parental OK cell line that lacks the expression of NHERF (3133). Vector (pcDNA 3.1Hygro+) transfected wild-type OK and OKH cells and OKH cells that were stably transfected with full-length human and PDZ domains–mutated NHERF-1 [hNHERF-1 (1-355)] were maintained at 37°C in a humidified atmosphere with 5% CO2 in DMEM/F12 medium (1:1) supplemented with 10% vol/vol FCS, penicillin (100 U/ml), and streptomycin (100 µg/ml) in presence of 600 U/ml hygromycin. The cells were fed twice a week and split once a week at a 1:4 ratio. All experiments were carried out using cells at 90 to 95% confluence. Cells that were grown on six-well culture plates were washed with serum-free medium 24 h before use.

Preparation and Purification of NHERF siRNA
NHERF siRNA sense and antisense oligonucleotides were designed by using Ambion’s web-based siRNA converter software (Austin, TX). The software identified a unique sequence (5'-AAGUCUAAGCCAGGCCAGGUUC-3') in the N-terminal region of NHERF against which siRNA was designed. The siRNA was prepared by using siRNA construction kit from Ambion according to the manufacturer’s protocol. Briefly, sense and antisense oligonucleotides were hybridized separately to T7 promoter primer followed by a Klenow DNA polymerase reaction. The sense and antisense siRNA templates were transcribed independently using T7 enzyme and mixed to form double-stranded siRNA (dsRNA). The siRNA was digested with RNase and DNase to remove the 5' overhanging leader sequences and DNA template. The resulting siRNA was purified by column purification.

Transfection of siRNA
One microgram of NHERF siRNA was transfected into OK cells using Genesilencer Transfection reagent according to the manufacturer’s protocol. Briefly, 5 µl of Genesilencer reagent was diluted with 25 µl of serum-free EMEM. In another tube, 1 µg of siRNA was diluted in 25 µl of siRNA diluent and 15 µl of serum-free EMEM. The siRNA-containing mixture was mixed with diluted Genesilencer reagent and incubated at room temperature for 15 min. The siRNA Genesilencer reagent mixture was added onto growing cells in serum-free EMEM and incubated at 37°C in 95% air/5% CO2 for 6 h, after which 1 ml of EMEM that contained 20% serum was added and further incubated for 24 h at 37°C in 95% air/5% CO2.

NHERF cDNA Transfection
Vector (pcDNA 3.1Hygro+) or human NHERF-1 and PDZ mutated human NHERF cDNA constructs in pcDNA 3.1Hygro+ were transfected into OKH cells using Geneporter transfection reagent according to the manufacturer’s protocol. Briefly, the cDNA and the Geneporter reagent were diluted separately in serum-free medium. The diluted cDNA was mixed with diluted Geneporter reagent and incubated at room temperature for 30 min. The culture medium from the cells was replaced with the mixture that contained Geneporter and NHERF cDNA and incubated for 24 h at 37°C in 95% air/5% CO2. The transfected cells were selected by growing them in 1000 U/ml hygromycin in a 96-well cell culture plate for 2 wk. Cells from the hygromycin-resistant wells were grown in DMEM/F12 that contained 600 U/ml hygromycin and 10% FCS. Expression of NHERF was confirmed by Western blot analysis.

Treatment with PTH
Unless otherwise stated, cells were treated for 15 min with 10–7 M PTH 1 to 34 at 37°C in 95% air/5% CO2.

Membrane Preparation
The cells were treated with 10–7 M PTH (bovine, 1 to 34) or vehicle, washed twice with PBS, and homogenized in 50 mM mannitol/5 mM Tris (pH 7.4), and the crude membranes were prepared as described previously (27).

Western Blot
Western blot analysis for NHERF, Na+,K+-ATPase {alpha}1 subunit, PKC{alpha}, and ezrin was performed exactly as described previously (27).

Determination of Na+,K+-ATPase Activity as K+-Dependent pNPPase Activity
Na+,K+-ATPase activity was measured as described previously (27) following the method of Hird et al. (35) with slight modifications as described by Tran and Farley (36).

Immunoprecipitation
The crude membranes were solubilized in IP buffer that contained 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 20 mM NaF, 1 mM EDTA, 1 mM EGTA, 5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 1 mM sodium pyrophosphate, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1% Triton X-100, 0.5% NP40, and 0.5% SDS and centrifuged at 70,000 x g for 1 h in a Beckman ultracentrifuge. Na+,K+-ATPase {alpha}1-subunit or PKC{alpha} was immunoprecipitated from 100 µg of supernatant protein overnight at 4°C as described previously (37). Western blotting was performed as previously reported (27).

Rubidium Uptake
Ouabain-sensitive rubidium (86Rb) uptake was measured as an index of Na+,K+-ATPase–mediated ion transport as described previously (37) following the method of Okafor et al. (38).

Determination of PKC{alpha} Activity
OK cells were incubated in the presence or absence of 10–7 M PTH for 15 min. The cells were washed two times with PBS (pH 7.4) and lysed in IP buffer. PKC{alpha} was immunoprecipitated from 100 µg of whole-cell lysate protein as described above. The beads were washed three times with IP buffer, and PKC activity was determined as described previously (37).

Confocal Imaging
Multichambered coverglass wells (Nunc, Naperville, CT) were seeded with OK cells. Cells were washed with serum-free medium 24 h before fixation. Cells were rinsed three times with PBS that contained calcium and magnesium, incubated in 4% paraformaldehyde in PBS for 10 min, rinsed five times with PBS, solubilized with 0.025% saponin in PBS for 15 min, incubated with an appropriate dilution of primary antibody (1:250 in PBS-Saponin for both NHERF and Na+,K+-ATPase {alpha}1 subunit antibodies) at 20°C, rinsed five times with PBS-Saponin, and incubated with appropriate Alexaflour secondary antibody (1:1000) conjugated to different fluorescence tags at 20°C. Alexaflour488 was used for identification of NHERF, and Alexaflour555 was used for identification of the {alpha} subunit. The cells were rinsed five times with PBS-Saponin, incubated with 300 nM DAPI for 5 min, rinsed three times with PBS, and mounted with 300 µl/well PBS. Images were acquired using a Zeiss confocal microscope and analyzed using LSM510 software. Z scan analysis on single cells was performed by scanning at 1-µm intervals and three-dimensional reconstruction of the fluorescence images. The images for NHERF and for the {alpha} subunit were merged in a single image to compare the cellular distribution of the two proteins.

Brush border membranes (BBM) and BLM were prepared from the same cell preparations as described previously (3,39). Protein concentration was measured by BCA method (Sigma) using BSA as standard.

Statistical Analyses
Data are shown as mean ± SEM. All experiments were repeated at least three times unless otherwise stated to document reproducibility. P value was calculated using SigmaStat software using paired t test. P < 0.05 was a priori considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
Characterization of Model Systems
We previously demonstrated that OK-WT express NHERF-1 (27). OKH cells, initially identified as OK cells with aberrant PTH signaling, exhibit significantly diminished NHERF-1 expression, as shown in Figure 1, confirming findings previously shown by other investigators (31); however, expression of Na+,K+-ATPase {alpha}1 subunit and ezrin in OKH cells was equivalent to OK-WT. The Western blot also indicates that PTH did not change the expression of Na+,K+-ATPase {alpha}1 subunit and ezrin in the crude membranes from OK-WT and OKH cells. We also developed from WT-OK strains with diminished NHERF-1 expression through the use of siRNA technology. Immunoblot analysis of NHERF siRNA OK-WT shows a marked reduction in NHERF-1 expression but intact expression of Na+,K+-ATPase {alpha}1 subunit and ezrin.



View larger version (23K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Comparison of expression of sodium hydrogen exchanger regulatory factor (NHERF), ezrin, and Na+,K+-ATPase {alpha}1 subunit in wild-type opossum kidney OK cells (OK-WT) and NHERF-deficient OK cells. (A) Crude membranes from OK-WT or NHERF-deficient OKH cells were separated by SDS-PAGE; transferred to solid matrix; and blotted for NHERF, Na+,K+-ATPase {alpha}1 subunit, and ezrin. (B) Crude membranes from OK-WT or OK-WT cells that were treated with siRNA for NHERF-1 (NHERF siRNA OK-WT) were separated by SDS-PAGE; transferred to solid matrix; and blotted for NHERF, Na+,K+-ATPase {alpha}1 subunit, and ezrin. Representative Western blots from three independent experiments are shown.

 
Effect of NHERF Deficiency on PTH Regulation of Na+,K+-ATPase Activity
To examine the effect of NHERF deficiency on regulation of the sodium pump, we compared Na+,K+-ATPase activity in OK-WT cells, OKH cells, and NHERF siRNA OK-WT cells. As seen in Figure 2A, treatment with 10–7 M PTH for 15 min produced an approximately 40% reduction in Na+,K+-ATPase activity in OK-WT cells but no reduction in OKH cells. PTH also had no effect on activity in NHERF siRNA OK-WT cells (Figure 2B).



View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Comparison of Na+,K+-ATPase activity in OK-WT and NHERF-deficient OK cells. OK cell monolayers were treated for 15 min with either vehicle or 10–7 M parathyroid hormone (PTH). The cells were lysed, and membrane fractions were isolated and assayed for Na+,K+-ATPase activity as described in Materials and Methods. Each bar represents Na+,K+-ATPase activity as µmol p-nitrophenol released/mg protein per min and is represented as mean ± SEM from three independent experiments. *Significantly different from control with P < 0.05. (A) Effect of PTH on OK-WT and OKH cells. (B) Effect of PTH on OK-WT cells that were treated with control siRNA for NHERF or active siRNA for NHERF.

 
Effect of NHERF Deficiency on Na+,K+-ATPase {alpha}1 Subunit Phosphorylation
PTH regulation of Na+,K+-ATPase activity requires phosphorylation of the {alpha}1 subunit accompanied by endocytosis of the subunit, resulting in decreased enzyme expression on the plasma membrane and therefore decreased activity (40). We previously demonstrated that expression of the NHERF construct lacking the ezrin-binding domain blocked PTH-stimulated phosphorylation of the {alpha}1 subunit (27). To determine whether NHERF deficiency had a similar inhibitory effect on PTH regulation, we measured PTH-stimulated phosphorylation of the {alpha}1 subunit in OK-WT, OKH, and NHERF siRNA OK-WT cells. As shown in Figure 3, PTH stimulated phosphorylation of Na+,K+-ATPase {alpha}1 subunit in OK-WT cells but not in NHERF-deficient models.



View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Comparison of PTH-stimulated phosphorylation of the Na+,K+-ATPase {alpha}1 subunit in OK-WT and NHERF-deficient OK cells. OK cells were treated for 15 min with vehicle or 10–7 M PTH followed by lysis of cells and preparation of crude membranes. The crude membranes were immunoprecipitated with antibody directed against the Na+,K+-ATPase {alpha}1 subunit and blotted for phosphoserine. A representative Western blot is shown. (A) Effect of PTH on {alpha}1 subunit phosphorylation in OK-WT and OKH cells. (B) Comparison for OK-WT cells that were treated with siRNA for NHERF or control siRNA. Bar diagrams show densitometry data as mean ± SEM from three independent experiments.

 
Effect of NHERF Deficiency on PTH Activation of Extracellular Signal-Regulated Kinase and PKC{alpha}
We have shown that PTH stimulation of PKC{alpha} through an extracellular signal-regulated kinase (ERK)-dependent pathway is critical for regulation of Na+,K+-ATPase activity (37). To determine whether PTH-stimulated activation of these signaling pathways was impaired in NHERF-deficient OKH cells, we examined the ability of PTH to stimulate ERK phosphorylation and PKC{alpha} translocation to the membrane fragment. As shown in Figure 4A, PTH stimulation of ERK phosphorylation is intact in the OKH model system. Western blot analysis of PKC{alpha} in the membrane fraction (Figure 4B) shows PTH-stimulated increased membrane expression of PKC{alpha} in OK-WT but not in NHERF-deficient OKH cells. A concomitant decrease in the PKC{alpha} expression was observed in the cytosol from OK-WT cells (data not shown).



View larger version (23K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Comparison of PTH-mediated extracellular signal-regulated kinase (ERK) phosphorylation and protein kinase C{alpha} (PKC{alpha}) translocation in OK-WT and OKH cells. OK cell monolayers were treated for 15 min with vehicle or 10–7 M PTH. (A) Cells were lysed in immunoprecipitation buffer, and lysate proteins were separated by SDS-PAGE, transferred to solid matrix, and blotted for phospho-ERK (active form) and total ERK. (B) Cells were washed and lysed in PKC lysis buffer, and membrane and cytosolic fractions were separated as described in Materials and Methods. The membrane proteins were separated by SDS-PAGE and transferred onto a solid phase, and the expression of PKC{alpha} was determined by Western blot analysis. Representative Western blots from three independent experiments are shown.

 
Role of PDZ Domains in Regulation of Na+,K+-ATPase Activity by PTH
For determining the roles of the PDZ domains in NHERF regulation of Na+,K+-ATPase by PTH, OKH cells were transfected with human NHERF-1 constructs, including full-length NHERF-1 and constructs expressing mutations in PDZ1, PDZ2, or both PDZ domains. Figure 5A shows successful transfection of these constructs into OKH cells and similar expression of Na+,K+-ATPase {alpha}1 subunit. Treatment with 10–7 M PTH for 15 min produced a significant inhibition in ouabain-sensitive 86Rb uptake, a measure of Na+,K+-ATPase activity, in OK-WT but not in OKH cells (Figure 5B). Transfection of full-length NHERF to OKH cells restored normal inhibition of 86Rb uptake by PTH, confirming that the defect in PTH regulation of Na+,K+-ATPase activity in OKH cells was due to NHERF deficiency. Basal Na+,K+-ATPase–mediated 86Rb uptake was significantly decreased in OKH cells that were transfected with NHERF construct expressing both PDZ mutations compared with the OK-WT or OKH cells and did not change significantly upon treatment with PTH. Similar to OKH cells that were transfected with full-length NHERF, cells expressing the PDZ2 mutation showed normal PTH-mediated inhibition of 86Rb uptake.



View larger version (32K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Comparison of Na+,K+-ATPase–mediated rubidium (86Rb) uptake in OKH cells that were transfected with NHERF-1 constructs. (A) Expression of full-length human NHERF-1 (OKH-N) or NHERF-1 constructs expressing null mutations in the PDZ1 domain (OKH-Z1), the PDZ2 domain (OKH-Z2), or both domains (OKH-BZ) stably transfected into OKH cells. (Bottom) Expression of Na+,K+-ATPase {alpha}1 subunit. Bar diagram shows densitometric data as mean ± SEM from three independent experiments. (B) OK cell monolayers of OK-WT, OKH, and OKH cells that were transfected with full-length NHERF-1 or NHERF-1 constructs and expressed mutations in the PDZ domains were treated for 15 min with vehicle or 10–7 M PTH. Ouabain-sensitive 86Rb uptake was performed in the intact cell monolayers as described in Materials and Methods. Each bar represents nM 86Rb/mg protein per min as mean ± SEM from three independent experiments. *Statistically significant difference between basal uptake in OK-WT and OKH cells expressing null mutations in NHERF-1 both PDZ domains; statistically significant difference between PTH-treated and vehicle-treated, P < 0.05.

 
Figure 6 shows the effect of transfection of the NHERF constructs on the ability of PTH to stimulate phosphorylation of the {alpha}1 subunit of Na+,K+-ATPase (Figure 6A) and activate PKC{alpha} (Figure 6B). As expected, PTH stimulated phosphorylation in OK-WT but not in OKH cells. Cells that were transfected with full-length NHERF or the NHERF construct expressing the mutated PDZ2 domain showed partial restoration of PTH-stimulated phosphorylation of the {alpha}1 subunit. In contrast, OKH cells that were transfected with the construct expressing the mutated PDZ1 domain failed to undergo {alpha}1 subunit phosphorylation in response to PTH. OKH cells that were transfected with the NHERF construct expressing both PDZ domain mutations have significantly increased basal phosphorylation of the {alpha}1 subunit that did not change with PTH treatment, indicated by densitometric analysis. PTH caused an approximately 50% increase in PKC{alpha} activity in OK-WT but not in OKH cells. PTH also significantly increased the activity of PKC{alpha} in OKH cells that were transfected with full-length NHERF-1 and PDZ2 mutated NHERF-1 but not in PDZ1 or both PDZ domain–mutated NHERF-1–transfected OKH cells.



View larger version (31K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. Comparison of PTH-stimulated Na+,K+-ATPase {alpha}1 subunit phosphorylation in OK cells expressing variable NHERF constructs. OK cell monolayers of OK-WT, OKH, and OKH cells that were transfected with full-length human NHERF-1 or NHERF-1 constructs expressing PDZ domain mutations were treated with vehicle or 10–7 M PTH for 15 min. The cells were lysed, and Na+,K+-ATPase {alpha}1 subunit was immunoprecipitated from crude membranes using anti–Na+,K+-ATPase {alpha}1 subunit antibody and blotted for phosphoserine. A representative Western blot is shown. (Bottom) Total Na+,K+-ATPase {alpha}1 subunit immunoprecipitated. Bar diagram shows densitometric data for phospho-serine blot as mean ± SEM from three independent experiments. *Statistically significant difference between PTH-treated and vehicle-treated cells (P < 0.05); significantly different from OK-WT control (P < 0.05). (B) Cells were washed and lysed, and PKC{alpha} was immunoprecipitated from whole-cell lysates with antibody directed against PKC{alpha}. The immunoprecipitated PKC{alpha} was assayed for activity as outlined in Materials and Methods. Activity is measured as ability to radiolabel a peptide substrate and expressed as pmol phosphate/min per mg protein. Each bar represents percentage change in PKC{alpha} activity (mean ± SEM) from three independent experiments. *Statistically significant difference between PTH-treated and vehicle-treated cells (P < 0.05).

 
Comparison of Cellular Distribution of NHERF and Na+,K+-ATPase {alpha}1 Subunit
Figure 7 shows the confocal images of OK cells stained with antibody for NHERF (green fluorescence) and the Na+,K+-ATPase {alpha}1 subunit (red fluorescence). OK-WT cells (Figure 7A) demonstrate a pattern of predominantly basolateral distribution of the {alpha}1 subunit. NHERF staining was observed at both the apical and the basolateral sides. OKH cells show a similar distribution for the {alpha}1 subunit but no detectable NHERF (Figure 7B). Figure 7C shows the distribution of NHERF and the {alpha}1 subunit in OKH cells that were transfected with full-length NHERF, demonstrating that the transfected protein assumes a similar distribution as the OK-WT cells. Similar distribution of NHERF and Na+,K+-ATPase {alpha}1 subunit was observed in NHERF mutant construct–transfected (PDZ1, PDZ2, and both PDZ domains) cells as seen in WT cells (data not shown). As other investigators have not consistently demonstrated basolateral expression of NHERF, BBM and BLM were prepared and subjected to Western blot analysis. As shown in Figure 7D, NHERF expression is observed in both the BBM and BLM preparations. BBM and BLM preparations were confirmed by Western blot analysis of NaPi-4 and Na+,K+-ATPase {alpha}1 subunit (Figure 7D, bottom).



View larger version (54K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. Comparison of the cellular distribution of NHERF and Na+,K+-ATPase {alpha}1 subunit. OK cell monolayers were double labeled with antibodies directed against NHERF (green fluorescence) and the Na+,K+-ATPase {alpha}1 subunit (red fluorescence). (A) Distribution of Na+,K+-ATPase {alpha}1 subunit (left), NHERF (middle), and merged image of Na+,K+-ATPase {alpha}1 subunit and NHERF (right) in OK-WT cells. (B) Distribution in OKH cells. (C) Distribution in OKH cells that were transfected with full-length NHERF-1. Representative confocal images from three independent experiments are shown. The far right panels show z-axis images of Na+,K+-ATPase {alpha}1 subunit (red staining), NHERF (green staining), and merged image of Na+,K+-ATPase {alpha}1 subunit and NHERF (yellow staining) with the apical side on the top and the basal side on the bottom. (D) Expression of NHERF in brush border membranes (BBM) and basolateral membranes (BLM). A representative Western blot is shown. Bar diagram shows densitometric data as mean ± SEM from three independent experiments.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 
We have demonstrated in two different models of NHERF-deficient OK proximal tubule cells that NHERF-1 is required for regulation of Na+,K+-ATPase activity by PTH. We also demonstrated that the PDZ1 domain is critical for this function. Transfection of NHERF-deficient cells with human NHERF-1 constructs that contained an intact PDZ 1 domain, specifically either full-length NHERF-1 or NHERF-1 with a null mutation in the PDZ2 domain, restored PTH regulation of the sodium pump. In contrast, expression of constructs that exhibited a null mutation in the PDZ1 domain failed to rescue PTH regulation of Na+,K+-ATPase activity. The requirement for an intact PDZ1 domain in PTH regulation of the sodium pump is consistent with previously published studies by Mahon and Segre (4) demonstrating that PTH activates an apical membrane complex in renal proximal tubule cells assembled through PTH1 receptor interaction with the PDZ1 domain of NHERF and consisting of the PTH1 receptor, PLC{beta}1, and actin. The authors showed that introduction into the cells of a peptide sequence identical to the PDZ1 domain of NHERF impaired apical membrane PTH1 receptor localization presumably through competition for binding of the PTH1 receptor and blocked PTH-stimulated intracellular calcium release.

Failure of PTH to inhibit Na+,K+-ATPase activity in the NHERF-deficient cells was accompanied by a failure to stimulate phosphorylation of the {alpha}1 subunit, which could be explained by a decrease in {alpha}1 subunit expression, failure to activate appropriate kinases, or inability of the kinases to reach the appropriate substrate. Both models of NHERF-deficient OK cells exhibited {alpha}1 subunit expression and baseline Na+,K+-ATPase activity that was equivalent to OK-WT. These findings, coupled with the confocal imaging studies, suggest that NHERF very likely does not play a dominant role in the plasma membrane localization of the components of the sodium pump. The diminished basal rubidium uptake in PDZ double-mutant cells despite the equivalent expression of the {alpha}1 subunit in the crude membrane preparation is somewhat at variance with this conclusion. As rubidium uptake tends to correlate with surface expression of the {alpha}1 subunit, this finding suggests that in OKH cells with the double PDZ mutation, {alpha}1 subunit may not be as efficiently expressed in the plasma membrane or may not be as fully active as WT. Further studies will be required to determine the effect of double mutations in NHERF PDZ domains in regulation of Na+,K+-ATPase activity and expression.

Our demonstration that the inability of PTH to inhibit sodium pump activity is correlated with an inability to activate PKC{alpha} in NHERF-deficient cells is consistent with previously published data from the laboratories of Cole (32,33) and of Mahon and Segre (4,5). Cole et al. (32) demonstrated that PTH stimulation of PKA in NHERF-deficient OKH cells was intact but that stimulation of intracellular calcium transients was not. Mahon et al. (4) furthered these observations by showing that NHERF-deficient OKH cells exhibit impaired activation of PLC through disruption of the protein complex required for PTH activation of this pathway. Whether the BLM of OK cells express the membrane protein complexes similar to those described in the apical membrane is not known. We showed recently that PTH activation of PKC{alpha} is essential for regulation of sodium pump activity and that the activation is ERK dependent (37). PTH stimulation of ERK phosphorylation is intact in NHERF-deficient cells, suggesting that activation of PKC{alpha} by PTH may depend on the simultaneous additive effects of both ERK and PLC.

From our data, we cannot determine the molecular mechanisms by which the PDZ1 domain mutation abolishes PTH regulation of the sodium pump. The mutation in the PDZ1 domain could result in a change in protein binding specific to the domain, or the mutation could result in misfolding that alters functions of the protein beyond the PDZ domain. Our confocal data show that the mutated NHERF traffics to the membrane in a normal distribution, suggesting that any misfolding that might occur is not as profound as to result in aberrant localization or in premature degradation. The question remains as to whether NHERF-1 binds the {alpha}1 subunit of Na+,K+-ATPase. Our confocal images and Western blots of isolated BLM show some localization of NHERF to the basolateral surface, suggesting that a direct NHERF-{alpha} subunit interaction could exist, contrasting the findings of Hernando et al. (20). These results, however, confirm the previous results by Bernardo et al. (41), who showed NHERF expression in BLM from rabbit kidney proximal tubules. From our data, we cannot determine whether NHERF binds directly to the {alpha}1 subunit of Na+,K+-ATPase. Scan of the sequence for the {alpha}1 subunit fails to disclose any known PDZ binding domain. These results do not exclude the possible presence of a nonclassical binding motif. Alternatively, the PDZ1 domain could mediate the association of the {alpha}1 subunit with the PTH1 receptor through interactions with other intermediary proteins, such as the {beta} subunit or the {gamma} subunit, or some other component of a signaling complex such as G{alpha}q (4246).

In conclusion, we have demonstrated that expression of the PDZ1 domain of NHERF-1 is critical for PTH regulation of Na+,K+-ATPase activity in renal proximal tubule cells. The role of this domain is to facilitate PTH receptor activation of the PLC/PKC pathway, a pathway that is critical for the phosphorylation and endocytosis of the {alpha}1 subunit of the sodium pump. Our findings also highlight contrasts between the mechanisms by which NHERF-1 mediates PTH regulation of two different transporters, the sodium pump and NHE-3. For the sodium pump, the PDZ1 domain of NHERF is required for PLC/PKC-mediated phosphorylation of the {alpha} subunit by facilitating the activation of this signaling pathway by PTH. For NHE-3, the PDZ2 domain of NHERF is required for PKA-mediated phosphorylation of the protein. These findings open the door to new mechanisms by which PTH can exert individualized regulation on its target proteins.


    Acknowledgments
 
This work was supported by the Veterans Administration (E.D.L., E.J.W., M.J.R.), the American Heart Association (S.J.K., M.J.R.), and the National Institutes of Health (E.J.W.).

We acknowledge the technical assistance of Nina Lesousky.


    Footnotes
 
Published online ahead of print. Publication date available at www.jasn.org.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Cell Culture
 Results
 Discussion
 References
 

  1. Feraille E, Doucet A: Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: Hormonal control. Physiol Rev 81 : 345 –418, 2001[Abstract/Free Full Text]
  2. Zhang Y, Norian JM, Magyar CE, Holstein-Rathlou NH, Mircheff AK, McDonough AA: In vivo PTH provokes apical NHE3 and NaPi-2 redistribution and Na-K ATPase inhibition. Am J Physiol 276 : F711 –F719, 1999
  3. Khundmiri SJ, Lederer ED: PTH and DA regulate Na-K ATPase through divergent pathways. Am J Physiol Renal Physiol 282 : F512 –F522, 2002[Abstract/Free Full Text]
  4. Mahon MJ, Segre GV: Stimulation by parathyroid hormone of a NHERF-1-assembled complex consisting of the parathyroid hormone I receptor, phospholipase Cbeta, and actin increases intracellular calcium in opossum kidney cells. J Biol Chem 279 : 23550 –23558, 2004[Abstract/Free Full Text]
  5. Mahon MJ, Donowitz M, Yun CC, Segre GV: Na (+)/H (+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417 : 858 –861, 2002[CrossRef][Medline]
  6. Weinman EJ: New functions for the NHERF family of proteins. J Clin Invest 108 : 185 –186, 2001[CrossRef][Medline]
  7. Weinman EJ, Steplock D, Tate K, Hall RA, Spurney RF, Shenolikar S: Structure-function of recombinant Na/H exchanger regulatory factor (NHE-RF). J Clin Invest 101 : 2199 –2206, 1998[Medline]
  8. Weinman EJ, Steplock D, Shenolikar S: NHERF-1 uniquely transduces the cAMP signals that inhibit sodium-hydrogen exchange in mouse renal apical membranes. FEBS Lett 536 : 141 –144, 2003[CrossRef][Medline]
  9. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ: Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci U S A 99 : 11470 –11475, 2002[Abstract/Free Full Text]
  10. Weinman EJ, Evangelista CM, Steplock D, Liu MZ, Shenolikar S, Bernardo A: Essential role for NHERF in cAMP-mediated inhibition of the Na+-HCO3— co-transporter in BSC-1 cells. J Biol Chem 276 : 42339 –42346, 2001[Abstract/Free Full Text]
  11. Weinman EJ, Steplock D, Shenolikar S: Acute regulation of NHE3 by protein kinase A requires a multiprotein signal complex. Kidney Int 60 : 450 –454, 2001[CrossRef][Medline]
  12. Wade JB, Liu J, Coleman RA, Cunningham R, Steplock DA, Lee-Kwon W, Pallone TL, Shenolikar S, Weinman EJ: Localization and interaction of NHERF isoforms in the renal proximal tubule of the mouse. Am J Physiol Cell Physiol 285 : C494 –C503, 2003
  13. Weinman EJ, Minkoff C, Shenolikar S: Signal complex regulation of renal transport proteins: NHERF and regulation of NHE3 by PKA. Am J Physiol Renal Physiol 279 : F393 –F399, 2003
  14. Weinman EJ, Steplock D, Donowitz M, Shenolikar S: NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3. Biochemistry 39 : 6123 –6129, 2000[CrossRef][Medline]
  15. Cunningham R, Steplock D, Wang F, Huang HEX, Shenolikar S, Weinman EJ: Defective PTH regulation of NHE3 activity and phosphate adaptation in cultured NHERF-1–/– renal proximal tubule cells. J Biol Chem 279 : 37815 –37821, 2004[Abstract/Free Full Text]
  16. Biber J: Emerging roles of transporter-PDZ complexes in renal proximal tubular reabsorption. Pflugers Arch 443 : 3 –5, 2001[CrossRef][Medline]
  17. Shenolikar S, Minkoff CM, Steplock DA, Evangelista C, Liu M, Weinman EJ: N-terminal PDZ domain is required for NHERF dimerization. FEBS Lett 489 : 233 –236, 2001[CrossRef][Medline]
  18. Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Gusella J, Ramesh V: NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 273 : 1273 –1276, 1998[Abstract/Free Full Text]
  19. Hall RA, Spurney RF, Premont RT, Rahman N, Blitzer JT, Pitcher JA, Lefkowitz RJ: G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem 274 : 24328 –24334, 1999[Abstract/Free Full Text]
  20. Hernando N, Deliot N, Gisler SM, Lederer E, Weinman EJ, Biber J, Murer H: PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters. Proc Natl Acad Sci U S A 99 : 11957 –11962, 2002[Abstract/Free Full Text]
  21. Tang Y, Tang J, Chen Z, Trost C, Flockerzi V, Li M, Ramesh V, Zhu MX: Association of mammalian trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF. J Biol Chem 275 : 37559 –37564, 2000[Abstract/Free Full Text]
  22. Liedtke CM, Raghuram V, Yun CC, Wang X: Role of a PDZ1 domain of NHERF1 in the binding of airway epithelial RACK1 to NHERF1. Am J Physiol Cell Physiol 286 : C1037 –C1044, 2004[Abstract/Free Full Text]
  23. Weinman EJ, Wang Y, Wang F, Greer C, Steplock D, Shenolikar S: A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange. Biochemistry 42 : 12662 –12668, 2003[CrossRef][Medline]
  24. Yoo D, Flagg TP, Olsen O, Raghuram V, Foskett JK, Welling PA: Assembly and trafficking of a multiprotein ROMK channel complex by PDZ interactions. J Biol Chem 279 : 6863 –6873, 2004[Abstract/Free Full Text]
  25. Benharouga M, Sharma M, So J, Haardt M, Drzymala L, Popov M, Schwapach B, Grinstein S, Du K, Lukacs GL: The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia. J Biol Chem 278 : 22079 –22089, 2003[Abstract/Free Full Text]
  26. Liedtke CM, Yun CH, Kyle N, Wang D: Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor. J Biol Chem 277 : 22925 –22933, 2002[Abstract/Free Full Text]
  27. Lederer ED, Khundmiri SJ, Weinman EJ: Role of NHERF-1 in regulation of the activity of Na-K ATPase and sodium-phosphate co-transport in epithelial cells. J Am Soc Nephrol 14 : 1711 –1719, 2003[Abstract/Free Full Text]
  28. Breton S, Wiederhold T, Marshansky V, Nsumu NN, Ramesh V, Brown D: The B1 subunit of the H+ ATPase is a PDZ domain-binding protein. Colocalization with NHE-RF in renal B-intercalated cells. J Biol Chem 275 : 18219 –18224, 2000[Abstract/Free Full Text]
  29. Pushkin A, Abuladze N, Newman D, Muronets V, Sassani P, Tatishchev S, Kurtz I: The COOH termini of NBC3 and the 56-kDa H+-ATPase subunit are PDZ motifs involved in their interaction. Am J Physiol Cell Physiol 284 : C667 –C673, 2003[Abstract/Free Full Text]
  30. Weinman EJ, Steplock D, Wade JB, Shenolikar S: Ezrin binding domain-deficient NHERF attenuates cAMP-mediated inhibition of Na(+)/H(+) exchange in OK cells. Am J Physiol Renal Physiol 281 : F374 –F380, 2001[Abstract/Free Full Text]
  31. Mahon MJ, Cole JA, Lederer ED, Segre GV: Na+/H+ exchanger-regulatory factor 1 mediates inhibition of phosphate transport by parathyroid hormone and second messengers by acting at multiple sites in opossum kidney cells. Mol Endocrinol 17 : 2355 –2364, 2003[Abstract/Free Full Text]
  32. Miyauchi A, Dobre V, Rickmeyer M, Cole J, Forte L, Hruska KA: Stimulation of transient elevations in cytosolic Ca2+ is related to inhibition of Pi transport in OK cells. Am J Physiol 259 : F485 –F493, 1990
  33. Cole JA, Forte LR, Krause WJ, Thorne PK: Clonal sublines that are morphologically and functionally distinct from parental OK cells. Am J Physiol 256 : F672 –F679, 1989
  34. Koyama H, Goodpasture C, Miller MM, Teplitz RL, Riggs AD: Establishment and characterization of a cell line from the American opossum ( Didelphys virginiana). In Vitro 14 : 239 –246, 1978
  35. Hird RB, Wakefield TW, Mukherjee R, Jones BU, Crawford FA, Andrews PC, Stanley JC, Spinale FG: Direct effects of protamine sulfate on myocyte contractile processes. Cellular and molecular mechanisms. Circulation 92 : 433 –446, 1995[Abstract/Free Full Text]
  36. Tran CM, Farley R: Photoaffinity labeling of the active site of the Na+/K(+)-ATPase with 4-azido-2-nitrophenyl phosphate. Biochemistry 35 : 47 –55, 1996[CrossRef][Medline]
  37. Khundmiri SJ, Dean WL, McLeish KR, Lederer ED: PTH-mediated regulation of Na+-K+-ATPase requires ERK-dependent translocation of PKCalpha. J Biol Chem 280 : 8705 –8713, 2005[Abstract/Free Full Text]
  38. Okafor MC, Mukhopadhyay P, Delamere NA: Studies on endothelin release and Na, K transport in porcine lens. Invest. Ophthalmol Vis Sci 43 : 790 –796, 2002[Abstract/Free Full Text]
  39. Khundmiri SJ, Rane MJ, Lederer ED: Parathyroid hormone regulation of type II sodium-phosphate cotransporters is dependent on an A kinase anchoring protein. J Biol Chem 278 : 10134 –10141, 2003[Abstract/Free Full Text]
  40. Khundmiri SJ, Bertorello AM, Delamere NA, Lederer ED: Clathrin-mediated endocytosis of Na+,K+-ATPase in response to parathyroid hormone requires ERK-dependent phosphorylation of Ser-11 within the alpha1-subunit. J Biol Chem 279 : 17418 –17427, 2004[Abstract/Free Full Text]
  41. Bernardo AA, Kear FT, Santos AV, Ma J, Steplock D, Robey RB, Weinman EJ: Basolateral Na(+)/HCO(3)(—) cotransport activity is regulated by the dissociable Na(+)/H(+) exchanger regulatory factor. J Clin Invest 104 : 195 –201, 1999[Medline]
  42. Kraemer DM, Strizek B, Meyer HE, Marcus K, Drenckhahn D: Kidney Na+, K+-ATPase is associated with moesin. Eur J Cell Biol 82 : 87 –92, 2003[Medline]
  43. Lopina OD: Interaction of Na,K-ATPase catalytic subunit with cellular proteins and other endogenous regulators. Biochemistry (Mosc) 66 : 1122 –1131, 2001[CrossRef][Medline]
  44. Thevananther S, Kolli AH, Devarajan P: Identification of a novel ankyrin isoform (AnkG190) in kidney and lung that associates with the plasma membrane and binds alpha-Na, K-ATPase. J Biol Chem 273 : 23952 –23958, 1998[Abstract/Free Full Text]
  45. Iida-Klein A, Guo J, Takemura M, Drake MT, Potts JT Jr, Abou-Samra A, Bringhurst FR, Segre GV: Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 72 : 6882 –6889, 1997
  46. Rochdi MD, Watier V, La Madeleine C, Nakata H, Kozasa T, Parent JL: Regulation of GTP-binding protein alpha q signaling by the ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50). J Biol Chem 277 : 40751 –40759, 2002[Abstract/Free Full Text]
Received for publication December 6, 2004. Accepted for publication June 6, 2005.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Y.-C. Chen, R. K. Meier, S. Zheng, S. J. Khundmiri, M. T. Tseng, E. D. Lederer, P. N. Epstein, and B. J. Clark
Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F380 - F388.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Hosojima, H. Sato, K. Yamamoto, R. Kaseda, T. Soma, A. Kobayashi, A. Suzuki, H. Kabasawa, A. Takeyama, K. Ikuyama, et al.
Regulation of Megalin Expression in Cultured Proximal Tubule Cells by Angiotensin II Type 1A Receptor- and Insulin-Mediated Signaling Cross Talk
Endocrinology, February 1, 2009; 150(2): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. J. Khundmiri, M. Ameen, N. A. Delamere, and E. D. Lederer
PTH-mediated regulation of Na+-K+-ATPase requires Src kinase-dependent ERK phosphorylation
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F426 - F437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. J. Khundmiri, A. Ahmad, R. E. Bennett, E. J. Weinman, D. Steplock, J. Cole, P. D. Baumann, J. Lewis, S. Singh, B. J. Clark, et al.
Novel regulatory function for NHERF-1 in Npt2a transcription
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F840 - F849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Voltz, M. Brush, S. Sikes, D. Steplock, E. J. Weinman, and S. Shenolikar
Phosphorylation of PDZ1 Domain Attenuates NHERF-1 Binding to Cellular Targets
J. Biol. Chem., November 16, 2007; 282(46): 33879 - 33887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Murtazina, O. Kovbasnjuk, N. C. Zachos, X. Li, Y. Chen, A. Hubbard, B. M. Hogema, D. Steplock, U. Seidler, K. M. Hoque, et al.
Tissue-specific Regulation of Sodium/Proton Exchanger Isoform 3 Activity in Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) Null Mice: cAMP INHIBITION IS DIFFERENTIALLY DEPENDENT ON NHERF1 AND EXCHANGE PROTEIN DIRECTLY ACTIVATED BY cAMP IN ILEUM VERSUS PROXIMAL TUBULE
J. Biol. Chem., August 24, 2007; 282(34): 25141 - 25151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wu, H. Kausar, P. Johnson, D. E. Montoya-Durango, M. Merchant, and M. J. Rane
Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex
J. Biol. Chem., July 27, 2007; 282(30): 21598 - 21608.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004121049v1
16/9/2598    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khundmiri, S. J.
Right arrow Articles by Lederer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khundmiri, S. J.
Right arrow Articles by Lederer, E.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP